Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $20.71 USD
Change Today -0.25 / -1.19%
Volume 724.6K
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Douglas C. Bryant

Chief Executive Officer, President and Director, Quidel Corp.
AgeTotal Calculated CompensationThis person is connected to 7 board members in 1 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Douglas C. Bryant, also known as Doug, has been the Chief Executive Officer and President of Quidel Corp. since March 1, 2009. Mr. Bryant served as the Chief Operating Officer and Executive Vice President of Luminex Corporation from July 16, 2007 to February 1, 2009. He oversaw all elements of Luminex's operations, including worldwide sales and marketing, its molecular diagnostics subsidiary, Luminex Molecular Diagnostics, the Luminex Bioscience Group, as well as ...

Read Full Background

Corporate Headquarters*

12544 High Bluff Drive
San Diego, California 92130

United States

Phone: 858-552-1100
Fax: 858-453-4338

Board Members Memberships*

Chief Executive Officer, President and Director


University of California, Davis

Other Affiliations*

Annual Compensation*

Total Annual Compensation$524,378

Stock Options*

Restricted Stock Awards$225,766
All Other Compensation$9,714
Exercisable Options1,085,305
Exercisable Options Value$17,177,828
Unexercisable Options270,914
Unexercisable Options Value$1,638,753
Total Value of Options$18,816,581
Total Number of Options1,356,219

Total Compensation*

Total Annual Cash Compensation$778,498
Total Short Term Compensation$524,378
Other Long Term Compensation$235,480
Total Calculated Compensation$2,057,262
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
QDEL:US $20.71 USD -0.25


Hany Massarany Chief Executive Officer, President and Director
GenMark Diagnostics, Inc.
John A. Krauetler Chairman of The Board, Chief Executive Officer and President
Meridian Bioscience, Inc.
Nachum Shamir Chief Executive Officer and President
Luminex Corporation
Douglas A. Michels Chief Executive Officer, President and Director
OraSure Technologies, Inc.
John P. McDonough Chief Executive Officer, President and Director
T2 Biosystems, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact QUIDEL CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at